CD40

Across TCGA pan-cancer cohorts, CD40 mass-spec protein differs between tumor and matched normal tissue in 6 of 18 cancer types tested, making tumor–normal expression one of CD40’s most consistent transcriptional readouts.

The strongest signal is observed in clear cell renal cell carcinoma (CCRCC), where CD40 mass-spec protein is more highly expressed in tumor relative to normal tissue. In most cancer types CD40 is over-expressed in tumor.

CCRCC, HNSC, and LSCC are the cancer types where CD40 tumor–normal differential expression is most reproducible.

mass-spec protein tumor vs normal associations by lineage

Ranked by sampling consensus. Fold-change is the tumor-versus-normal difference in CD40 mass-spec protein (log₂); positive values indicate higher expression in tumor. p-values are from the differential-expression test.

Lineage	Gender	Stage	Fold-change	p	Sampling consensus
CCRCC	Male	IV	+1.324	<.001	11	view →
HNSC	Male	IV	+0.628	<.001	8	view →
LSCC	All	All	+0.220	<.001	7	view →
COAD	Female	II,III,IV	+0.360	.013	5	view →
PDAC	All	II,III,IV	+0.327	.009	4	view →
LUAD	All	All	+0.143	.009	3	view →

Pink = over-expressed in tumor, green = repressed in tumor. Showing the 6 strongest of 6 lineages.

CD40–CCRCC

Open the CCRCC breakdown →